Derma Sciences (NASDAQ: DSCI) reported Q4 EPS of ($0.27), $0.04 better than the analyst estimate of ($0.31) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE